Note*: This report requires 7-10 business days to complete.
DelveInsight’s Clostridium difficile (CDID) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Clostridium difficile (CDID) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Clostridium difficile (CDID) till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Clostridium difficile (CDID) market.
• Identifying patient populations in the global “Clostridium difficile (CDID)market to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Clostridium difficile (CDID) therapeutics in each of the markets covered.
• To understand the future market competition in the global Clostridium difficile (CDID) therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Clostridium difficile (CDID) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Clostridium difficile (CDID) overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Clostridium difficile (CDID) Market
• Global Epidemiology of Clostridium difficile (CDID) Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Clostridium difficile (CDID) Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Clostridium difficile (CDID) (2013-2023)
• Table 7: Clostridium difficile (CDID) Global Market (USD Millions), (2013-2015)
• Table 8: Clostridium difficile (CDID) Global Market (USD Millions), (2016-2023)
• Table 9: Clostridium difficile (CDID) US Market (USD Millions), (2013-2015)
• Table 10: Clostridium difficile (CDID) US Market (USD Millions), (2016-2023)
• Table 11: Clostridium difficile (CDID) Germany Market (USD Millions), (2013-2015)
• Table 12: Clostridium difficile (CDID) Germany Market (USD Millions), (2016-2023)
• Table 13: Clostridium difficile (CDID) United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Clostridium difficile (CDID) United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Clostridium difficile (CDID) France Market (USD Millions), (2013-2015)
• Table 16: Clostridium difficile (CDID) France Market (USD Millions), (2016-2023)
• Table 17: Clostridium difficile (CDID) Italy Market (USD Millions), (2013-2015)
• Table 18: Clostridium difficile (CDID) Italy Market (USD Millions), (2016-2023)
• Table 19: Clostridium difficile (CDID) Spain Market (USD Millions), (2013-2015)
• Table 20: Clostridium difficile (CDID) Spain Market (USD Millions), (2016-2023)
• Table 21: Clostridium difficile (CDID) Japan Market (USD Millions), (2013-2015)
• Table 22: Clostridium difficile (CDID) Japan Market (USD Millions), (2016-2023)
• Table 23: Clostridium difficile (CDID) ROW Market (USD Millions), (2013-2015)
• Table 24: Clostridium difficile (CDID) ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Clostridium difficile (CDID) Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Clostridium difficile (CDID) (2013-2023)
• Figure 3: Clostridium difficile (CDID) Global Market (USD Millions), (2013-2015)
• Figure 4: Clostridium difficile (CDID) Global Market (USD Millions), (2016-2023)
• Figure 5: Clostridium difficile (CDID) US Market (USD Millions), (2013-2015)
• Figure 6: Clostridium difficile (CDID) US Market (USD Millions), (2016-2023)
• Figure 7: Clostridium difficile (CDID) Germany Market (USD Millions), (2013-2015)
• Figure 8: Clostridium difficile (CDID) Germany Market (USD Millions), (2016-2023)
• Figure 9: Clostridium difficile (CDID) United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Clostridium difficile (CDID) United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Clostridium difficile (CDID) France Market (USD Millions), (2013-2015)
• Figure 12: Clostridium difficile (CDID) France Market (USD Millions), (2016-2023)
• Figure 13: Clostridium difficile (CDID) Italy Market (USD Millions), (2013-2015)
• Figure 14: Clostridium difficile (CDID) Italy Market (USD Millions), (2016-2023)
• Figure 15: Clostridium difficile (CDID) Spain Market (USD Millions), (2013-2015)
• Figure 16: Clostridium difficile (CDID) Spain Market (USD Millions), (2016-2023)
• Figure 17: Clostridium difficile (CDID) Japan Market (USD Millions), (2013-2015)
• Figure 18: Clostridium difficile (CDID) Japan Market (USD Millions), (2015-2023)
• Figure 19: Clostridium difficile (CDID) ROW Market (USD Millions), (2013-2015)
• Figure 20: Clostridium difficile (CDID) ROW Market (USD Millions), (2016-2023)
• Merck & Co. Inc.
• Sanofi
• Synthetic Biologics Inc.
• Astellas Pharma Inc.
• Actelion Ltd
• Pfizer Inc.
• Seres Therapeutics Inc.
• Bio-K Plus International Inc.
• Summit Therapeutics Plc
• Da Volterra
